Show items per page
Elements: 6
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
A European multicentre PET study of fibrillar amyloid in Alzheimer's disease Nordberg, Agneta; Carter, Stephen F; Rinne, Juha; Drzezga, Alexander; ... Herholz, Karl 2013
add to browser selection
Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI. Caroli, Anna; Prestia, Annapaola; Wade, Sara; Chen, Kewei; ... Frisoni, Giovanni 2014
add to browser selection
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework Garibotto, Valentina; Herholz, Karl; Boccardi, Marina; Picco, Agnese; ... Ratib, Osman 2017
add to browser selection
Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework Chiotis, Konstantinos; Saint-Aubert, Laure; Boccardi, Marina; Gietl, Anton; ... Nordberg, Agneta 2017
add to browser selection
Clinical validity of presynaptic dopaminergic imaging with 123I-ioflupane and noradrenergic imaging with 123I-MIBG Sonni, Ida; Ratib, Osman; Boccardi, Marina; Picco, Agnese; ... Varrone, Andrea 2017
add to browser selection
Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer's disease Drzezga, Alexander; Altomare, Daniele; Festari, Cristina; Arbizu, Javier; ... Boccardi, Marina 2018